NRGN
Neurogranin
Also known as: NEUG_HUMAN, RC3
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q92686
- Gene
- NRGN
- Ensembl
- ENSG00000154146
- Chromosome
- 11
- Canonical length
- 78 aa
- Protein class
- Predicted intracellular proteins
OverviewNCBI Gene
Neurogranin (NRGN) is the human homolog of the neuron-specific rat RC3/neurogranin gene. This gene encodes a postsynaptic protein kinase substrate that binds calmodulin in the absence of calcium. The NRGN gene contains four exons and three introns. The exons 1 and 2 encode the protein and exons 3 and 4 contain untranslated sequences. It is suggested that the NRGN is a direct target for thyroid hormone in human brain, and that control of expression of this gene could underlay many of the consequences of hypothyroidism on mental states during development as well as in adult subjects. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
78 residues, UniProt reviewed canonical sequence.
>Q92686|NRGN
1 MDCCTENACS KPDDDILDIP LDDPGANAAA AKIQASFRGH MARKKIKSGE RGRKGPGPGG
61 PGGAGVARGG AGGGPSGDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against NRGN can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.63
- Highest tissue expression
- 2,193 nTPM
Expression across tissuesHPA
Tissue
- cerebral cortex: 2,193 nTPM
- basal ganglia: 1,839 nTPM
- amygdala: 932 nTPM
- hippocampal formation: 781 nTPM
- hypothalamus: 136 nTPM
- midbrain: 93 nTPM
Single-cell type
- platelets: 12,504 nCPM
- megakaryocytes: 2,361 nCPM
- brain excitatory neurons: 188 nCPM
- megakaryocyte progenitors: 152 nCPM
- vascular smooth muscle cells: 132 nCPM
- brain inhibitory neurons: 126 nCPM
Immune cell
- total PBMC: 6.8 nTPM
- classical monocyte: 3.6 nTPM
- neutrophil: 2.5 nTPM
- intermediate monocyte: 2.1 nTPM
- myeloid DC: 1.8 nTPM
- basophil: 1.7 nTPM
Brain region
- cerebral cortex: 3,357 nTPM
- white matter: 2,232 nTPM
- basal ganglia: 2,125 nTPM
- hippocampal formation: 910 nTPM
- amygdala: 792 nTPM
- hypothalamus: 640 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.44
- gnomAD pLI
- 0.48
- gnomAD missense Z
- 1.7
- DepMap mean gene effect
- 0.12
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- associative learning
- nervous system development
- positive regulation of long-term synaptic potentiation
- postsynaptic modulation of chemical synaptic transmission
- signal transduction
- telencephalon development
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NRGN as an antibody target. Whether an autoantibody or antibody against NRGN could matter depends on whether native NRGN is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NRGN is annotated at the cell surface, where native NRGN is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label NRGN as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...